1 | matched | 5,774 |
2 | mismatched | 115 |
3 | cancer-free | 76 |
4 | wait-listed | 67 |
5 | nourished | 64 |
6 | well-matched | 56 |
7 | pair-matched | 53 |
8 | score-matched | 47 |
9 | segregating | 38 |
10 | frequency-matched | 23 |
11 | case-matched | 22 |
12 | wesdr | 13 |
13 | screen-negative | 12 |
14 | normed | 11 |
15 | non-matched | 10 |
16 | similar-sized | 10 |
17 | disease-matched | 6 |
18 | kpm | 6 |
19 | non-disease | 6 |
20 | non-pci-treated | 6 |
21 | nonmatched | 6 |
22 | self-motivated | 6 |
23 | acei+bb | 5 |
24 | chd-free | 5 |
25 | new-user | 5 |
26 | status-matched | 5 |
27 | area-matched | 4 |
28 | gestation-matched | 4 |
29 | groups-a | 4 |
30 | level-matched | 4 |
31 | overencapsulated | 4 |
32 | 5.7±1.2 | 3 |
33 | 9003 | 3 |
34 | drug-ae | 3 |
35 | mh-susceptible | 3 |
36 | non-deficient | 3 |
37 | outscored | 3 |
38 | placebo.at | 3 |
39 | pre-cooled | 3 |
40 | self-reportedly | 3 |
41 | units/positive | 3 |
42 | 1,943 | 2 |
43 | 14,728 | 2 |
44 | 40/604 | 2 |
45 | act-funded | 2 |
46 | adjective-noun | 2 |
47 | age-similar | 2 |
48 | category/attribute | 2 |
49 | diagnosis-therapy | 2 |
50 | fitness-matched | 2 |
51 | index-partner | 2 |
52 | information/education-only | 2 |
53 | matched-control | 2 |
54 | non-energy-containing | 2 |
55 | non-sham | 2 |
56 | nondementia | 2 |
57 | nonetched | 2 |
58 | paludigenum | 2 |
59 | patient-proxy | 2 |
60 | performance-matched | 2 |
61 | sigmoidoscopy-negative | 2 |
62 | student-population | 2 |
63 | sweetness-matched | 2 |
64 | time-and-attention | 2 |
65 | unii | 2 |
66 | vs.14 | 2 |
67 | waitlist/placebo | 2 |
68 | -and-sex-based | 1 |
69 | -andes | 1 |
70 | .twelve | 1 |
71 | 0.05+/-0.07 | 1 |
72 | 0.1+/-0.3 | 1 |
73 | 1,488,474 | 1 |
74 | 153,279 | 1 |
75 | 2.3+/-1.9 | 1 |
76 | 2.7+/-3.3 | 1 |
77 | 22,511 | 1 |
78 | 25/71 | 1 |
79 | 35.6±32.3 | 1 |
80 | 36.4±0.8°c | 1 |
81 | 4,519 | 1 |
82 | 5-untreated | 1 |
83 | 50-gene | 1 |
84 | 522,839 | 1 |
85 | 56.4° | 1 |
86 | 59285 | 1 |
87 | all-program | 1 |
88 | becaplermin/127 | 1 |
89 | beginning/n-25 | 1 |
90 | beginning/n-26 | 1 |
91 | biopsy/tumor | 1 |
92 | chaperonin-containing | 1 |
93 | ct-dicom | 1 |
94 | drenthe | 1 |
95 | drug-event | 1 |
96 | fractures.seven | 1 |
97 | gender-divided | 1 |
98 | gestionnal | 1 |
99 | intervention/4 | 1 |
100 | low-bp | 1 |
101 | mass-scaled | 1 |
102 | mg/racing | 1 |
103 | mother-cb | 1 |
104 | mother-neonate | 1 |
105 | mother/neonate | 1 |
106 | negative/unscheduled | 1 |
107 | non-ccdss | 1 |
108 | non-mcs | 1 |
109 | non-nfa | 1 |
110 | np-np | 1 |
111 | oseltamivir/65 | 1 |
112 | parturient-neonate | 1 |
113 | patient-medication | 1 |
114 | pcr-primer | 1 |
115 | picture-shock | 1 |
116 | pm/120 | 1 |
117 | polyene-based | 1 |
118 | pre-pregnantly | 1 |
119 | program-treatment | 1 |
120 | protocol-publication | 1 |
121 | pseudovalidation | 1 |
122 | sah-free | 1 |
123 | scribed | 1 |
124 | sex-city-setting | 1 |
125 | smoker-family | 1 |
126 | sparrow-weavers | 1 |
127 | symptom-criteria | 1 |
128 | tdcs-naïve | 1 |
129 | transm | 1 |
130 | treatment+7,066 | 1 |
131 | ubiquitin-injected | 1 |
132 | word-gesture | 1 |
133 | work-eligible | 1 |
134 | zanamivir/65 | 1 |
1 | -and-sex-based | 1 |
2 | -andes | 1 |
3 | .twelve | 1 |
4 | 0.05+/-0.07 | 1 |
5 | 0.1+/-0.3 | 1 |
6 | 1,488,474 | 1 |
7 | 1,943 | 2 |
8 | 14,728 | 2 |
9 | 153,279 | 1 |
10 | 2.3+/-1.9 | 1 |
11 | 2.7+/-3.3 | 1 |
12 | 22,511 | 1 |
13 | 25/71 | 1 |
14 | 35.6±32.3 | 1 |
15 | 36.4±0.8°c | 1 |
16 | 4,519 | 1 |
17 | 40/604 | 2 |
18 | 5-untreated | 1 |
19 | 5.7±1.2 | 3 |
20 | 50-gene | 1 |
21 | 522,839 | 1 |
22 | 56.4° | 1 |
23 | 59285 | 1 |
24 | 9003 | 3 |
25 | acei+bb | 5 |
26 | act-funded | 2 |
27 | adjective-noun | 2 |
28 | age-similar | 2 |
29 | all-program | 1 |
30 | area-matched | 4 |
31 | becaplermin/127 | 1 |
32 | beginning/n-25 | 1 |
33 | beginning/n-26 | 1 |
34 | biopsy/tumor | 1 |
35 | cancer-free | 76 |
36 | case-matched | 22 |
37 | category/attribute | 2 |
38 | chaperonin-containing | 1 |
39 | chd-free | 5 |
40 | ct-dicom | 1 |
41 | diagnosis-therapy | 2 |
42 | disease-matched | 6 |
43 | drenthe | 1 |
44 | drug-ae | 3 |
45 | drug-event | 1 |
46 | fitness-matched | 2 |
47 | fractures.seven | 1 |
48 | frequency-matched | 23 |
49 | gender-divided | 1 |
50 | gestation-matched | 4 |
51 | gestionnal | 1 |
52 | groups-a | 4 |
53 | index-partner | 2 |
54 | information/education-only | 2 |
55 | intervention/4 | 1 |
56 | kpm | 6 |
57 | level-matched | 4 |
58 | low-bp | 1 |
59 | mass-scaled | 1 |
60 | matched | 5,774 |
61 | matched-control | 2 |
62 | mg/racing | 1 |
63 | mh-susceptible | 3 |
64 | mismatched | 115 |
65 | mother-cb | 1 |
66 | mother-neonate | 1 |
67 | mother/neonate | 1 |
68 | negative/unscheduled | 1 |
69 | new-user | 5 |
70 | non-ccdss | 1 |
71 | non-deficient | 3 |
72 | non-disease | 6 |
73 | non-energy-containing | 2 |
74 | non-matched | 10 |
75 | non-mcs | 1 |
76 | non-nfa | 1 |
77 | non-pci-treated | 6 |
78 | non-sham | 2 |
79 | nondementia | 2 |
80 | nonetched | 2 |
81 | nonmatched | 6 |
82 | normed | 11 |
83 | nourished | 64 |
84 | np-np | 1 |
85 | oseltamivir/65 | 1 |
86 | outscored | 3 |
87 | overencapsulated | 4 |
88 | pair-matched | 53 |
89 | paludigenum | 2 |
90 | parturient-neonate | 1 |
91 | patient-medication | 1 |
92 | patient-proxy | 2 |
93 | pcr-primer | 1 |
94 | performance-matched | 2 |
95 | picture-shock | 1 |
96 | placebo.at | 3 |
97 | pm/120 | 1 |
98 | polyene-based | 1 |
99 | pre-cooled | 3 |
100 | pre-pregnantly | 1 |
101 | program-treatment | 1 |
102 | protocol-publication | 1 |
103 | pseudovalidation | 1 |
104 | sah-free | 1 |
105 | score-matched | 47 |
106 | screen-negative | 12 |
107 | scribed | 1 |
108 | segregating | 38 |
109 | self-motivated | 6 |
110 | self-reportedly | 3 |
111 | sex-city-setting | 1 |
112 | sigmoidoscopy-negative | 2 |
113 | similar-sized | 10 |
114 | smoker-family | 1 |
115 | sparrow-weavers | 1 |
116 | status-matched | 5 |
117 | student-population | 2 |
118 | sweetness-matched | 2 |
119 | symptom-criteria | 1 |
120 | tdcs-naïve | 1 |
121 | time-and-attention | 2 |
122 | transm | 1 |
123 | treatment+7,066 | 1 |
124 | ubiquitin-injected | 1 |
125 | unii | 2 |
126 | units/positive | 3 |
127 | vs.14 | 2 |
128 | wait-listed | 67 |
129 | waitlist/placebo | 2 |
130 | well-matched | 56 |
131 | wesdr | 13 |
132 | word-gesture | 1 |
133 | work-eligible | 1 |
134 | zanamivir/65 | 1 |
1 | pm/120 | 1 |
2 | 22,511 | 1 |
3 | 25/71 | 1 |
4 | 5.7±1.2 | 3 |
5 | 0.1+/-0.3 | 1 |
6 | 35.6±32.3 | 1 |
7 | 2.7+/-3.3 | 1 |
8 | 9003 | 3 |
9 | 1,943 | 2 |
10 | intervention/4 | 1 |
11 | 40/604 | 2 |
12 | vs.14 | 2 |
13 | 1,488,474 | 1 |
14 | beginning/n-25 | 1 |
15 | zanamivir/65 | 1 |
16 | oseltamivir/65 | 1 |
17 | 59285 | 1 |
18 | beginning/n-26 | 1 |
19 | treatment+7,066 | 1 |
20 | 0.05+/-0.07 | 1 |
21 | becaplermin/127 | 1 |
22 | 14,728 | 2 |
23 | 2.3+/-1.9 | 1 |
24 | 4,519 | 1 |
25 | 522,839 | 1 |
26 | 153,279 | 1 |
27 | groups-a | 4 |
28 | non-nfa | 1 |
29 | symptom-criteria | 1 |
30 | nondementia | 2 |
31 | acei+bb | 5 |
32 | mother-cb | 1 |
33 | 36.4±0.8°c | 1 |
34 | scribed | 1 |
35 | gender-divided | 1 |
36 | act-funded | 2 |
37 | matched | 5,774 |
38 | area-matched | 4 |
39 | performance-matched | 2 |
40 | score-matched | 47 |
41 | case-matched | 22 |
42 | disease-matched | 6 |
43 | level-matched | 4 |
44 | well-matched | 56 |
45 | gestation-matched | 4 |
46 | non-matched | 10 |
47 | pair-matched | 53 |
48 | sweetness-matched | 2 |
49 | fitness-matched | 2 |
50 | status-matched | 5 |
51 | frequency-matched | 23 |
52 | nonmatched | 6 |
53 | mismatched | 115 |
54 | nonetched | 2 |
55 | nourished | 64 |
56 | mass-scaled | 1 |
57 | pre-cooled | 3 |
58 | negative/unscheduled | 1 |
59 | normed | 11 |
60 | outscored | 3 |
61 | polyene-based | 1 |
62 | -and-sex-based | 1 |
63 | non-pci-treated | 6 |
64 | 5-untreated | 1 |
65 | overencapsulated | 4 |
66 | self-motivated | 6 |
67 | ubiquitin-injected | 1 |
68 | wait-listed | 67 |
69 | similar-sized | 10 |
70 | drug-ae | 3 |
71 | chd-free | 5 |
72 | sah-free | 1 |
73 | cancer-free | 76 |
74 | drenthe | 1 |
75 | work-eligible | 1 |
76 | mh-susceptible | 3 |
77 | 50-gene | 1 |
78 | word-gesture | 1 |
79 | non-disease | 6 |
80 | mother-neonate | 1 |
81 | parturient-neonate | 1 |
82 | mother/neonate | 1 |
83 | category/attribute | 2 |
84 | screen-negative | 12 |
85 | sigmoidoscopy-negative | 2 |
86 | units/positive | 3 |
87 | .twelve | 1 |
88 | tdcs-naïve | 1 |
89 | mg/racing | 1 |
90 | chaperonin-containing | 1 |
91 | non-energy-containing | 2 |
92 | segregating | 38 |
93 | sex-city-setting | 1 |
94 | unii | 2 |
95 | picture-shock | 1 |
96 | gestionnal | 1 |
97 | matched-control | 2 |
98 | non-sham | 2 |
99 | all-program | 1 |
100 | ct-dicom | 1 |
101 | kpm | 6 |
102 | transm | 1 |
103 | paludigenum | 2 |
104 | fractures.seven | 1 |
105 | patient-medication | 1 |
106 | protocol-publication | 1 |
107 | pseudovalidation | 1 |
108 | student-population | 2 |
109 | time-and-attention | 2 |
110 | adjective-noun | 2 |
111 | waitlist/placebo | 2 |
112 | low-bp | 1 |
113 | np-np | 1 |
114 | age-similar | 2 |
115 | wesdr | 13 |
116 | pcr-primer | 1 |
117 | index-partner | 2 |
118 | new-user | 5 |
119 | biopsy/tumor | 1 |
120 | non-mcs | 1 |
121 | -andes | 1 |
122 | sparrow-weavers | 1 |
123 | non-ccdss | 1 |
124 | placebo.at | 3 |
125 | non-deficient | 3 |
126 | program-treatment | 1 |
127 | drug-event | 1 |
128 | self-reportedly | 3 |
129 | smoker-family | 1 |
130 | information/education-only | 2 |
131 | pre-pregnantly | 1 |
132 | diagnosis-therapy | 2 |
133 | patient-proxy | 2 |
134 | 56.4° | 1 |